Market Overview

Benzinga's Top #PreMarket Losers

Related TRGT
Alzheimer's Rates Falling, But Pharma's Search For A Cure Yields No Results
News Targacept's Key Drug Failed Phase 2b Trial Shaves 16% From Shares
Related RMTI
Benzinga's Volume Movers
Morning Market Movers

Targacept (NASDAQ: TRGT) shares fell 31.93% to $4.05 in the pre-market trading after the company announced negative top-line results from Phase 2b clinical trial of TC-5619 in Schizophrenia.

Rockwell Medical (NASDAQ: RMTI) dipped 12.03% to $11.85. Brean Capital initiated coverage on the stock with a Sell rating.

Expedia (NASDAQ: EXPE) dipped 7.47% to $60.96 in the pre-market session. Expedia's trailing-twelve-month profit margin is 3.15%.

Fiserv (NASDAQ: FISV) shares dropped 3.21% to $54.87 in pre-market trading. Fiserv's PEG ratio is 2.67.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Most Popular

Related Articles (EXPE + FISV)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free